There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.  

There have been many recent studies that further differentiate gynecologic cancers and their management relating to pathologic features, such as molecular status.

There are many strategies for managing brain mets with radiotherapy.

Over the past five years, multiple advances in diagnostic imaging, molecular stratification, and neurosurgical and radiotherapeutic approaches have changed the multi-disciplinary management of meningioma, the most common intracranial tumor.

The role of this activity reviews growing indications for radiation therapy for liver cancer, educates providers on radiation therapy options (SBRT, particle therapy) and the potential impact of hepatic reserve capacity on decision making, explores challenges and opportunities for clinical trials

There are many effective liver-directed loco-regional therapies for limited liver metastases including advanced techniques/approaches in surgery, radiation therapy, and interventional radiology.

Patients with head and neck cancer require specialized and multi-modality support during treatment. Providers may not be informed of the most up-to-date techniques to prevent and treat head and neck cancer radiation-related toxicity.

The clinical practice regarding feeding tube use in patients undergoing radiotherapy for head and neck cancer varies greatly. Ongoing research advances, as well as indications for feeding tube use in contemporary practices are required to provide optimal care.

The 2024 ASTRO Advocacy Update provides participants with an opportunity to better understand how ASTRO advocates for policies that benefit radiation oncology on Capitol Hill.